CU6 1.63% $7.49 clarity pharmaceuticals ltd

Research/Valuation, page-353

  1. 2,807 Posts.
    lightbulb Created with Sketch. 2885
    @ma420 a short attack only works if there is a fundamental flaw in the stock (I.e. overvalued/more likely to fail than succeed). I think CU6 wouldn’t be at the top of the list to short there are plenty of others out there.

    If it runs hard or receives a takeover offer the short squeeze would just drive things higher. The ETFs forced to buy would add further demand and thus less to go around. Economics 101!
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.